ATE109978T1 - Verwendung von purpuromycin zur behandlung von vaginalinfektionen. - Google Patents

Verwendung von purpuromycin zur behandlung von vaginalinfektionen.

Info

Publication number
ATE109978T1
ATE109978T1 AT90105203T AT90105203T ATE109978T1 AT E109978 T1 ATE109978 T1 AT E109978T1 AT 90105203 T AT90105203 T AT 90105203T AT 90105203 T AT90105203 T AT 90105203T AT E109978 T1 ATE109978 T1 AT E109978T1
Authority
AT
Austria
Prior art keywords
purpuromycin
vaginal infections
vaginalis
treat vaginal
antibiotic
Prior art date
Application number
AT90105203T
Other languages
English (en)
Inventor
Francesco Parenti
Beth P Goldstein
Luigi Simioni
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE109978T1 publication Critical patent/ATE109978T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
AT90105203T 1989-03-31 1990-03-20 Verwendung von purpuromycin zur behandlung von vaginalinfektionen. ATE109978T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89105686 1989-03-31
EP89109272 1989-05-23

Publications (1)

Publication Number Publication Date
ATE109978T1 true ATE109978T1 (de) 1994-09-15

Family

ID=26120030

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90105203T ATE109978T1 (de) 1989-03-31 1990-03-20 Verwendung von purpuromycin zur behandlung von vaginalinfektionen.

Country Status (10)

Country Link
US (1) US5141953A (de)
EP (1) EP0389924B1 (de)
JP (1) JPH02289514A (de)
KR (1) KR900013971A (de)
AT (1) ATE109978T1 (de)
AU (1) AU628946B2 (de)
CA (1) CA2013277A1 (de)
DE (1) DE69011557T2 (de)
HU (1) HU207655B (de)
IL (1) IL93866A0 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0447813A1 (de) * 1990-02-28 1991-09-25 GRUPPO LEPETIT S.p.A. Wasserlösliche Salze von Purpuromycin und dieses enthaltende pharmazeutische Zusammensetzungen
IT1253711B (it) * 1991-12-17 1995-08-23 Alfa Wassermann Spa Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
US7439271B2 (en) * 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
EP1468517B1 (de) * 2002-01-04 2016-03-30 Nokia Technologies Oy Senden und empfangen mit sende-diversity mit hoher rate
US20050215634A1 (en) * 2003-11-11 2005-09-29 Schlievert Patrick M Regulation of cell membrane-mediated effects
US8796332B2 (en) 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
KR20190026686A (ko) 2016-07-08 2019-03-13 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 벤지다민을 포함하는 약학적 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1455128A (en) * 1973-03-19 1976-11-10 Lepetit Spa Purpuromycin and its derivatives

Also Published As

Publication number Publication date
AU628946B2 (en) 1992-09-24
CA2013277A1 (en) 1990-09-30
EP0389924A2 (de) 1990-10-03
US5141953A (en) 1992-08-25
HUT54299A (en) 1991-02-28
DE69011557T2 (de) 1995-03-23
AU5206390A (en) 1990-10-04
KR900013971A (ko) 1990-10-22
JPH02289514A (ja) 1990-11-29
EP0389924A3 (de) 1991-08-14
HU207655B (en) 1993-05-28
IL93866A0 (en) 1990-12-23
EP0389924B1 (de) 1994-08-17
HU901897D0 (en) 1990-07-28
DE69011557D1 (de) 1994-09-22

Similar Documents

Publication Publication Date Title
DE3881299D1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
BR9306040A (pt) Tratamento e profilaxia de doenças provocadas por parasitos ou bactérias
RU94041950A (ru) Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
ES2056963T3 (es) Agentes antibacterianos.
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
DE69221501T2 (de) Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen
ES2187667T3 (es) Uso de relaxina para estimular angiogenesis.
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
ATE81776T1 (de) Verwendung von chinolon und naphthyridinantibiotika zur herstellung von ophthalmischen arzneimitteln.
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE109978T1 (de) Verwendung von purpuromycin zur behandlung von vaginalinfektionen.
OA09917A (en) Compounds for use in treating HIV infection
RU94021356A (ru) Способ лечения протозойных инфекций бацитрацином, применение соли бацитрацина для производства лекарственного препарата
ES2159294T3 (es) Metodo y composicion para el tratamiento de la caida del cabello.
DK120892D0 (da) Treatment and prophylaxis of diseases caused by parasites, fungi or bacteria
MX9304878A (es) Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.
DE195749T1 (de) Verwendung von benzydamin zur behandlung von trichomonas-vaginalis- und gardnerella-vaginalis-infektionen.
DE69210737T2 (de) Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen
AU3612689A (en) Veterinary composition containing ampicillin and cloxacillin for treating eye infection
DE59305285D1 (de) Transdermales therapeutisches system mit pentylentetrazol als wirkstoff
RU92004825A (ru) Мазь для лечения гнойных ран
MX9204845A (es) Combinaciones de compuestos de cloruro de amonio ymetodo para el tratamiento de infecciones virales.
MX9400210A (es) Tratamiento de infecciones virales.
RU96114051A (ru) Способ лечения экземы у травматолого-ортопедических больных с гнойной инфекцией
RU2001106308A (ru) Способ лечения гнойных инфекций